Rachel S. van Leeuwaarde

Author

Also Known As

Emma R. Woodward, R. S. van Leeuwaarde, R.S. Van Leeuwaarde, R.S. van Leeuwaarde, Rachel Leeuwaarde, Rachel S van Leeuwaarde, Rachel S. Van Leewaarde, Rachel S. van Leeuwaarde, Rachel Sera Leeuwaarde, Rachel S. van Leeuwaarde

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht University Medical Center Groningen Radboud University Nijmegen Radboud University Medical Center University of Groningen

About

Rachel S. van Leeuwaarde is an author at University Medical Center Utrecht specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	84
2	Health Sciences	1	1	74
3	Public Health	1	1	10
4	Biostatistics	1	1	10
5	Epidemiology	1	1	10

Rachel S. van Leeuwaarde

Publications

731

Citations

H-Index

Page 1

	Year	Citations
Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1—Results From the Dutch MEN1 Study Group Carolina R C Pieterman, Joanne M. de Laat, Jos W. R. Twisk, The Journal of Clinical Endocrinology & Metabolism	2017	74
Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study Arthur J. A. T. Braat, Rutger C. G. Bruijnen, Rob van Rooij, The Lancet Oncology HepatologyAdditional Holmium-166 RadioembolisationMedicineRadionuclide TherapyLiver Physiology	2020	74
Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites Talya L. Dayton, Nicolas Alcala, Laura Moonen, Cancer Cell	2023	69
MEN1-Dependent Breast Cancer: Indication for Early Screening? Results From the Dutch MEN1 Study Group Rachel S. van Leeuwaarde, Koen M.A. Dreijerink, Margreet G.E.M. Ausems, The Journal of Clinical Endocrinology & Metabolism	2017	66
Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study Mark J C van Treijen, Catharina M. Korse, Rachel S. van Leeuwaarde, Frontiers in Endocrinology	2018	57
Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study Group Rachel S. van Leeuwaarde, Bernadette P. M. van Nesselrooij, Ad R. Hermus, The Journal of Clinical Endocrinology & Metabolism	2016	52
High Fear of Disease Occurrence Is Associated With Low Quality of Life in Patients With Multiple Endocrine Neoplasia Type 1: Results From the Dutch MEN1 Study Group Rachel S. van Leeuwaarde, Carolina R C Pieterman, Eveline M. A. Bleiker, The Journal of Clinical Endocrinology & Metabolism	2018	44
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%? Elettra Merola, Teresa Alonso Gordoa, Panpan Zhang, The Oncologist	2020	40
The Management of Neuroendocrine Tumors of the Lung in MEN1: Results From the Dutch MEN1 Study Group Medard F. M. van den Broek, Joanne M. de Laat, Rachel S. van Leeuwaarde, The Journal of Clinical Endocrinology & Metabolism	2020	30
Health-Related Quality of Life in Patients with Multiple Endocrine Neoplasia Type 1 Rachel S. van Leeuwaarde, Carolina R C Pieterman, Anne M. May, Neuroendocrinology	2020	29

Page 1